What are the Precautions and Monitoring Requirements?
Patients on Lorlatinib require routine monitoring of blood lipid levels, liver function tests, and mental status examinations. It is important to discuss all potential drug interactions with healthcare providers, as Lorlatinib can interact with other medications metabolized through the CYP3A pathway. Additionally, women of childbearing potential should use effective contraception during treatment and for at least one month after the last dose.
